These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2412541)

  • 21. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
    McAleer JJ; Nicholls J; Horwich A
    Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors.
    von Eyben FE; Skude G; Fosså SD; Klepp O; Børmer O
    Mol Gen Genet; 1983; 189(2):326-33. PubMed ID: 6190072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients.
    Socinski MA; Garnick MB
    Ann Intern Med; 1988 Apr; 108(4):567-8. PubMed ID: 2450502
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
    Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
    Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of testicular cancer.
    Ellis M; Sikora K
    Drugs Exp Clin Res; 1986; 12(1-3):219-31. PubMed ID: 2426072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
    Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
    Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs).
    Newlands ES; Holden L; Bagshawe KD
    Int J Biol Markers; 1988; 3(3):185-92. PubMed ID: 2466094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumours.
    Oliver RT; Blandy JP; Hendry WF; Pryor JP; Williams JP; Hope-Stone HF
    Br J Urol; 1983 Dec; 55(6):764-8. PubMed ID: 6652449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
    Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
    Childs WJ; Goldstraw P; Nicholls JE; Dearnaley DP; Horwich A
    Br J Cancer; 1993 May; 67(5):1098-101. PubMed ID: 8494705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
    Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Toner GC; Schraffordt Koops H; Mulders PF; Messemer JE; Ney K; Donohue JP
    J Clin Oncol; 1995 May; 13(5):1177-87. PubMed ID: 7537801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
    Steyerberg EW; Keizer HJ; Zwartendijk J; Van Rijk GL; Van Groeningen CJ; Habbema JD; Stoter G
    Br J Cancer; 1993 Jul; 68(1):195-200. PubMed ID: 8318413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late relapse of testicular cancer.
    Terebelo HR; Taylor HG; Brown A; Martin N; Stutz FH; Blom J; Geier L
    J Clin Oncol; 1983 Sep; 1(9):566-71. PubMed ID: 6668516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alphafetoprotein and germ cell neoplasms.
    Hayatnagarkar NP; Deshpande AD; Solanki BR
    Indian J Med Res; 1980 Aug; 72():269-72. PubMed ID: 6164638
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders.
    Moore MR; Garrett PR; Walton KN; Waldmann TA; McIntire RK; Vogel CL
    Surg Gynecol Obstet; 1978 Aug; 147(2):167-74. PubMed ID: 80036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.